Constitutive activation of the Nrf2/Keap1 pathway due to the defective proteasomal degradation of Nrf2 protects cancer cells from ROS toxicity and promotes HCC tumor growth. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.